Kevin Kedra
Stock Analyst at Gabelli & Co.
(2.46)
# 2,219
Out of 4,789 analysts
18
Total ratings
37.5%
Success rate
22.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Kedra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITRM Iterum Therapeutics | Upgrades: Hold | n/a | $1.17 | - | 2 | Jul 27, 2021 | |
| ELAN Elanco Animal Health | Upgrades: Buy | n/a | $10.35 | - | 2 | May 11, 2021 | |
| ASRT Assertio Holdings | Upgrades: Buy | n/a | $0.66 | - | 1 | Apr 9, 2021 | |
| LXRX Lexicon Pharmaceuticals | Upgrades: Buy | n/a | $0.46 | - | 8 | Nov 18, 2020 | |
| ZTS Zoetis | Downgrades: Hold | n/a | $161.91 | - | 2 | Aug 12, 2020 | |
| PAHC Phibro Animal Health | Downgrades: Hold | n/a | $21.97 | - | 3 | Feb 6, 2020 |
Iterum Therapeutics
Jul 27, 2021
Upgrades: Hold
Price Target: n/a
Current: $1.17
Upside: -
Elanco Animal Health
May 11, 2021
Upgrades: Buy
Price Target: n/a
Current: $10.35
Upside: -
Assertio Holdings
Apr 9, 2021
Upgrades: Buy
Price Target: n/a
Current: $0.66
Upside: -
Lexicon Pharmaceuticals
Nov 18, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.46
Upside: -
Zoetis
Aug 12, 2020
Downgrades: Hold
Price Target: n/a
Current: $161.91
Upside: -
Phibro Animal Health
Feb 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $21.97
Upside: -